|
Volumn 11, Issue 18, 2001, Pages 2457-2460
|
Modulation of human mammary cell sensitivity to paclitaxel by new quinoline sulfonamides
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CHLOROQUINE;
PACLITAXEL;
PRIMAQUINE;
QUINOLINE SULFONAMIDE;
SB RA 30001;
SB RA 31012;
SULFONAMIDE;
TAXANE DERIVATIVE;
UNCLASSIFIED DRUG;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
BREAST CARCINOMA;
BREAST CELL;
CANCER CELL CULTURE;
CHEMOSENSITIVITY;
CONCENTRATION RESPONSE;
CONTROLLED STUDY;
DRUG ACTIVITY;
DRUG CYTOTOXICITY;
DRUG EFFICACY;
DRUG POTENCY;
DRUG SCREENING;
DRUG SENSITIVITY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
GROWTH INHIBITION;
HUMAN;
HUMAN CELL;
IC 50;
MOLECULAR MODEL;
MULTIDRUG RESISTANCE;
PHARMACOPHORE;
ANTIMALARIALS;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
BREAST NEOPLASMS;
DRUG DESIGN;
DRUG RESISTANCE, MULTIPLE;
DRUG RESISTANCE, NEOPLASM;
DRUG SCREENING ASSAYS, ANTITUMOR;
HUMANS;
INHIBITORY CONCENTRATION 50;
MODELS, MOLECULAR;
PACLITAXEL;
QUINOLINES;
STRUCTURE-ACTIVITY RELATIONSHIP;
SULFONAMIDES;
TUMOR CELLS, CULTURED;
MAMMARIA;
|
EID: 0035903869
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0960-894X(01)00462-0 Document Type: Article |
Times cited : (9)
|
References (18)
|